| For: | Luo C, Zheng ZG, Zeng MQ, Xu H, Yu XM, Sun D, He DJ. Curcumol targets the FTO/MAFG-AS1 axis to alleviate diabetic retinopathy via epigenetic remodeling and nanodelivery-based microenvironment modulation. World J Diabetes 2025; 16(6): 107017 [PMID: 40585189 DOI: 10.4239/wjd.v16.i6.107017] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i6/107017.htm |
| Number | Citing Articles |
| 1 |
Jie Yang, Jun Liao, Bi-Wen Mo, Yan Gao, Yun-Xiang Chen, Yue Gu, Miao-Miao Liang, Hui-Min Li. The orchestrated interplay between DNA methylation and N6-methyladenosine modification: status quo and future perspectives. PeerJ 2026; 14 doi: 10.7717/peerj.20654
|
| 2 |
Qiong Wu, Pan Pan Ma. Glycosylation gene-based molecular recognition model for diabetic retinopathy. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1721094
|
| 3 |
Min Zhou, Lan Liu, Yihong Sun, Xiaoshu Wang. Lactylation in diabetes mellitus and its complications: mechanisms of action and therapeutic potential - recent advances. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1710645
|
| 4 |
Wenyao Zhang, Jinying Chen, Jingxiang Zhong. Regulatory mechanisms and therapeutic potential of N6-methyladenosine modification in retinal diseases (Review). Molecular Medicine Reports 2026; 34(1) doi: 10.3892/mmr.2026.13923
|